Elevai Labs, Inc. (ELAB) Ownership
ELAB ownership summary
as of October 18, 2026- Institutions
- 3.3% of shares outstanding
- Insiders
- 5.61% of shares outstanding
- Shares outstanding
- 810K
- Float
- 764K shares available to trade
- Short interest
- 3.41% 28K shares short
- Days to cover
- 0.54 short interest down 19.7% vs prior month
- Institutions 3.28%
- Insiders 5.61%
- Other investors 91.11%
ELAB top institutional holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Jane Street Group LLC | 1.01% | 82K | $225,758 | +49,907 (+158.0%) | June 30, 2026 |
| 2 | Morgan Stanley - Brokerage Accounts | 0.65% | 53K | $146,810 | +38,000 (+253.3%) | June 30, 2026 |
| 3 | Vanguard Fiduciary Trust Co | 0.42% | 34K | $94,219 | +34,014 (0.0%) | June 30, 2026 |
| 4 | Geode Capital Management, LLC | 0.30% | 24K | $66,693 | +24,077 (0.0%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 0.21% | 17K | $46,181 | +16,672 (0.0%) | June 30, 2026 |
| 6 | Virtu Financial LLC | 0.21% | 17K | $46,007 | +16,609 (0.0%) | June 30, 2026 |
| 7 | XTX Topco Ltd | 0.17% | 14K | $39,190 | +14,148 (0.0%) | June 30, 2026 |
| 8 | Tower Research Capital LLC | 0.03% | 2,505 | $6,939 | +2,376 (+1,841.9%) | June 30, 2026 |
| 9 | UBS Group AG | 0.03% | 2,352 | $6,515 | +1,050 (+80.6%) | June 30, 2026 |
| 10 | IFP Advisors, LLC | 0.01% | 1,000 | $2,770 | −1,000 (−50.0%) | June 30, 2026 |
| 11 | Danske Bank A/S. | 0.00% | 1 | $3 | +1 (0.0%) | June 30, 2026 |
| 12 | Schonfeld Strategic Advisors LLC | 0.00% | — | — | −14,800 (−100.0%) | June 30, 2026 |
| 13 | Bank of America Corp | 0.00% | — | — | −2 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 13, 10 holders added 197K shares and 3 cut 16K.
ELAB top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.57% | 4,636 | $12,842 | +2,228 (+92.5%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | 0.11% | 900 | $2,493 | +900 (0.0%) | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.05% | 378 | $1,047 | +378 (0.0%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ELAB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ELAB
Institutional investors own 3.3% of Elevai Labs's shares and insiders 5.61%. The largest holder is Jane Street Group LLC with 1.01% of the shares (82K), as of June 30, 2026. Among the top 13 institutions, 10 added shares and 3 reduced their stake in the latest filings. Short interest is 3.41% of the float, or 0.54 days of average trading volume. The share count fell 82.5% since 2022.
Related: ELAB key metrics. See the ELAB stock overview for the latest quote and news.
ELAB ownership FAQ
Who owns the most Elevai Labs stock?
The largest shareholders of Elevai Labs are Jane Street Group LLC (1.01%), Morgan Stanley - Brokerage Accounts (0.65%), Vanguard Fiduciary Trust Co (0.42%), Geode Capital Management, LLC (0.30%), Vanguard Capital Management, LLC (0.21%).
What percentage of Elevai Labs is owned by institutions?
Institutions hold 3.3% of Elevai Labs's shares outstanding; insiders hold 5.61%.
Which funds own Elevai Labs?
The largest fund holders of Elevai Labs are Fidelity Extended Market Index (0.57%), Fidelity Series Total Market Index (0.11%), Fidelity Total Market Index (0.05%).
What is Elevai Labs's short interest?
28K shares of Elevai Labs were sold short, 3.41% of the float; at the average daily volume it would take 0.54 days to cover.
How many shares of Elevai Labs are outstanding?
Elevai Labs has 810K shares outstanding, of which 764K are in the public float.